Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'H-1-ANTAGONISTS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 110 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Chishty, M; Reichel, A; Siva, J; Abbott, NJ; Begley, DJ
      Affinity for the P-glycoprotein efflux pump at the blood-brain barrier mayexplain the lack of CNS side-effects of modern antihistamines

      JOURNAL OF DRUG TARGETING
    2. Furue, M; Terao, H; Koga, T
      Effects of cetirizine and epinastine on the skin response to histamine iontophoresis

      JOURNAL OF DERMATOLOGICAL SCIENCE
    3. Kamei, C
      Involvement of central histamine in amygdaloid kindled seizures in rats

      BEHAVIOURAL BRAIN RESEARCH
    4. Ten Eick, AP; Blumer, JL; Reed, MD
      Safety of antihistamines in children

      DRUG SAFETY
    5. Brown, AFT; McKinnon, D
      Emergency department anaphylaxis: A review of 142 patients in a single year

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    6. De Ponti, F; Poluzzi, E; Montanaro, N
      Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: A call for consensus

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    7. Shamsi, Z; Kimber, S; Hindmarch, I
      An investigation into the effects of cetirizine on cognitive function and psychomotor performance in healthy volunteers

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    8. Walsh, GM; Annunziato, L; Frossard, N; Knol, K; Levander, S; Nicolas, JM; Taglialatela, M; Tharp, MD; Tillement, JP; Timmerman, H
      New insights into the second generation antihistamines

      DRUGS
    9. Shishoo, CJ; Shirsath, VS; Rathod, IS; Patil, MJ; Bhargava, SS
      Design, synthesis and antihistaminic (H-1) activity of some condensed 2-(substituted) arylaminoethylpyrimidin-4(3H)-ones

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    10. Alper, BS
      Choice of antihistamines for urticaria

      ARCHIVES OF FAMILY MEDICINE
    11. Lorette, G; Giannetti, A; Pereira, RS; Leynadier, F; Murrieta-Aguttes, M
      One-year treatment of chronic urticaria with mizolastine: efficacy and safety

      JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
    12. Gentile, DA; Friday, GA; Skoner, DP
      Management of allergic rhinitis - Antihistamines and decongestants

      IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
    13. Shamsi, Z; Hindmarch, I
      Sedation and antihistamines: A review of inter-drug differences using proportional impairment ratios

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    14. Pradalier, A; Campinos, C; Barzegar, C; Vincent, D
      Cardiovascular side-effects of antihistamines

      REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE
    15. Shishoo, CJ; Shirsath, VS; Rathod, IS; Yande, VD
      Design, synthesis and antihistaminic (H-1) activity of some condensed 3-aminopyrimidin-4(3H)-ones

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    16. van der Goot, H; Timmerman, H
      Selective ligands as tools to study histamine receptors

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    17. Fadel, R; Ramboer, I; Chatterjee, N; Rihoux, JP; Derde, MP
      Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopicand healthy subjects (vol 55, pg 382, 2000)

      ALLERGY
    18. Abdelaziz, MM; Khair, OA; Devalia, JL
      The potential of active metabolites of antihistamines in the management ofallergic disease

      ALLERGY
    19. Fadel, R; Ramboer, I; Chatterjee, N; Rihoux, JP; Derde, MP
      Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopicand healthy subjects

      ALLERGY
    20. Baroody, FM; Naclerio, RM
      Antiallergic effects of H-1-receptor antagonists

      ALLERGY
    21. Timmerman, H
      Factors involved in the absence of sedative effects by the second-generation antihistamines

      ALLERGY
    22. Walczynski, K; Guryn, R; Zuiderveld, OP; Zhang, MQ; Timmerman, H
      Histamine H-1 receptor ligands Part II. Synthesis and in vitro pharmacology of 2-[2-(phenylamino)thiazol-4-yl]ethanamine and 2-(2-benzhydrylthiazol-4-yl)ethanamine derivatives

      FARMACO
    23. Hurst, M; Spencer, CM
      Ebastine - An update of its use in allergic disorders

      DRUGS
    24. Hamelin, BA; Bouayad, A; Methot, J; Jobin, J; Desgagnes, P; Poirier, P; Allaire, J; Dumesnil, J; Turgeon, J
      Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or lowCYP2D6 activity

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    25. Gilbert, JD; Cahill, SA; McCartney, DG; Lukas, A; Gross, GJ
      Predictors of Torsades de Pointes in rabbit ventricles perfused with sedating and nonsedating histamine H-1-receptor antagonists

      CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    26. Taglialatela, M; Pannaccione, A; Castaldo, P; Giorgio, G; Annunziato, L
      Inhibition of HERG1 K+ channels by the novel second-generation antihistamine mizolastine

      BRITISH JOURNAL OF PHARMACOLOGY
    27. Meltzer, EO; Grant, JA
      Impact of cetirizine on the burden of allergic rhinitis

      ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    28. Zuberbier, T; Henz, BM
      Use of cetirizine in dermatologic disorders

      ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    29. Zhou, ZF; Vorperian, VR; Gong, QM; Zhang, ST; January, CT
      Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole

      JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    30. Timmerman, H
      Why are non-sedating antihistamines non-sedating?

      CLINICAL AND EXPERIMENTAL ALLERGY
    31. Cuss, FM
      Beyond the histamine receptor: effect of antihistamines on mast cells

      CLINICAL AND EXPERIMENTAL ALLERGY
    32. Simons, FER
      Non-cardiac adverse effects of antihistamines (H-1-receptor antagonists)

      CLINICAL AND EXPERIMENTAL ALLERGY
    33. Hindmarch, I; Shamsi, Z
      Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects

      CLINICAL AND EXPERIMENTAL ALLERGY
    34. Dubertret, L; Aguttes, MM; Tonet, J
      Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR study

      JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
    35. Blazso, G; Razga, Z; Gabor, M
      Effects of cinnarizine on different experimentally induced oedemas

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    36. Simons, FER
      Clinical pharmacology of new H-1-receptor antagonists, and why it matters

      REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE
    37. Bayramgurler, D; Bilen, N; Apaydyn, R; Altintas, L; Sal, G; Dokmeci, S; Utkan, T
      Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses

      CLINICAL AND EXPERIMENTAL DERMATOLOGY
    38. Hindmarch, I; Shamsi, Z; Stanley, N; Fairweather, DB
      A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    39. Zimmermann, P; Privou, C; Huston, JP
      Differential sensitivity of the caudal and rostral nucleus accumbens to the rewarding effects of a H1-histaminergic receptor blocker as measured withplace-preference and self-stimulation behavior

      NEUROSCIENCE
    40. Scadding, GK; Tasman, AJ; Murrieta-Aguttes, M; Bachert, C
      Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    41. Battaglia, S; Boldrini, E; Da Settimo, F; Dondio, G; La Motta, C; Marini, AM; Primofiore, G
      Indole amide derivatives: synthesis, structure-activity relationships and molecular modelling studies of a new series of histamine H-1-receptor antagonists

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    42. DuBuske, LM
      Second-generation antihistamines: The risk of ventricular arrhythmias

      CLINICAL THERAPEUTICS
    43. Horak, F; Stubner, UP
      Comparative tolerability of second generation antihistamines

      DRUG SAFETY
    44. Grant, JA; Danielson, L; Rihoux, JP; DeVos, C
      A double-blind, single-dose, crossover comparison of cetirizine, ebastine,epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in

      ALLERGY
    45. Borici-Mazi, R; Kouridakis, S; Kontou-Fili, K
      Cutaneous responses to substance P and calcitonin gene-related peptide in chronic urticaria: the effect of cetirizine and dimethindene

      ALLERGY
    46. Sussman, GL; Mason, J; Compton, D; Stewart, J; Ricard, N
      The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone andin combination, in seasonal allergic rhinitis

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    47. Simons, FER; Roberts, JR; Gu, XC; Kapur, S; Simons, KJ
      The clinical pharmacology of brompheniramine in children

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    48. Mattila, MJ; Paakkari, I
      Variations among non-sedating antihistamines: are there real differences?

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    49. Suzuki, T; Mori, T; Tsuji, M; Nomura, M; Misawa, M; Onodera, K
      Evaluation of the histamine H-1-antagonist-induced place preference in rats

      JAPANESE JOURNAL OF PHARMACOLOGY
    50. Walczynski, K; Timmerman, H; Zuiderveld, OP; Zhang, MQ; Glinka, R
      Histamine H-1 receptor ligands Part I. Novel thiazol-4-ylethanamine derivatives: synthesis and in vitro pharmacology

      FARMACO
    51. Walczynski, K; Guryn, R; Zuiderweld, OP; Timmerman, H
      Non-imidazole histamine H-3 ligands. Part I. Synthesis of 2-(1-piperazinyl)- and 2-(hexahydro-1H-1,4-diazepin-1-yl)benzothiazole derivatives as H-3-antagonists with H-1 blocking activities

      FARMACO
    52. Chachin, M; Katayama, Y; Yamada, M; Horio, Y; Ohmura, T; Kitagawa, H; Uchida, S; Kurachi, Y
      Epinastine, a nonsedating histamine H-1 receptor antagonist, has a negligible effect on HERG channel

      EUROPEAN JOURNAL OF PHARMACOLOGY
    53. Slater, JW; Zechnich, AD; Haxby, DG
      Second-generation antihistamines - A comparative review

      DRUGS
    54. Davies, RJ
      Efficacy and tolerability comparison of ebastine 10 and 20mg with loratadine 10mg - A double-blind, randomised study in patients with perennial allergic rhinitis

      CLINICAL DRUG INVESTIGATION
    55. THODEN WR; DRUCE HM; FUREY SA; LOCKHART EA; RATNER P; HAMPEL FC; VANBAVEL J
      BROMPHENIRAMINE MALEATE - A DOUBLE-BLIND, PLACEBO-CONTROLLED COMPARISON WITH TERFENADINE FOR SYMPTOMS OF ALLERGIC RHINITIS

      American journal of rhinology
    56. ALBANESI C; PASTORE S; FANALESBELASIO E; GIROLOMONI G
      CETIRIZINE AND HYDROCORTISONE DIFFERENTIALLY REGULATE ICAM-1 EXPRESSION AND CHEMOKINE RELEASE IN CULTURED HUMAN KERATINOCYTES

      Clinical and experimental allergy
    57. Bachert, C
      Histamine - a major role in allergy?

      CLINICAL AND EXPERIMENTAL ALLERGY
    58. Bousquet, J
      Antihistamines in severe/chronic rhinitis

      CLINICAL AND EXPERIMENTAL ALLERGY
    59. GONZALEZ MA; ESTES KS
      PHARMACOKINETIC OVERVIEW OF ORAL 2ND-GENERATION H-1 ANTIHISTAMINES

      International journal of clinical pharmacology and therapeutics
    60. SCHULZE FR; BUSCHAUER A; SCHUNACK W
      COMBINED HISTAMINE H-1 H-2 RECEPTOR ANTAGONISTS - PART-I - PHARMACOLOGICAL HYBRIDS WITH PHENIRAMINE-LIKE AND ROXATIDINE-LIKE SUBSTRUCTURES/

      European journal of pharmaceutical sciences
    61. WOLF C; SCHULZE FR; BUSCHAUER A; SCHUNACK W
      COMBINED HISTAMINE H-1 H-2 RECEPTOR ANTAGONISTS - PART-II - PHARMACOLOGICAL HYBRIDS WITH PHENIRAMINE-LIKE AND TIOTIDINE-LIKE SUBSTRUCTURES/

      European journal of pharmaceutical sciences
    62. KAMEI C; ISHIZAWA K; KAKINOKI H; FUKUNAGA M
      HISTAMINERGIC MECHANISMS IN AMYGDALOID-KINDLED SEIZURES IN RATS

      Epilepsy research
    63. Simons, R; Estelle, F
      Clinical pharmacology of new H-1-receptor antagonists, and why it matters

      REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE
    64. Stern, M; Blondin-Ertzbischoff, P; Murrieta-Aguttes, M; Hardwicke, C; Emmerson, EBM; Judd, MS
      Rapid and sustained efficacy of mizolastine 10 mg once daily in seasonal allergic rhinitis

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    65. ZWAAGSTRA ME; KORTHOUWER REM; TIMMERMAN H; ZHANG MQ
      SYNTHESIS OF 3-SUBSTITUTED AND 5'-SUBSTITUTED FLAVONE-8-CARBOXYLIC ACIDS AS 3-ARMED LEUKOTRIENE CYSLT(1) RECEPTOR ANTAGONISTS

      European journal of medicinal chemistry
    66. TADANO T; AGATSUMA Y; OYAMA K; HOZUMI M; MORIKAWA Y; KISARA K; ARAI Y; YASUHARA H; TABATA A; KINEMUCHI H
      THE ROLE OF CENTRAL HISTAMINERGIC NEURONS IN HEAD-TWITCHES INDUCED BYP-HYDROXYAMPHETAMINE

      Biogenic amines
    67. GIBBS BF; VOLLRATH IB; ALBRECHT C; AMON U; WOLFF HH
      INHIBITION OF INTERLEUKIN-4 AND INTERLEUKIN-13 RELEASE FROM IMMUNOLOGICALLY ACTIVATED HUMAN BASOPHILS DUE TO THE ACTIONS OF ANTIALLERGIC DRUGS

      Naunyn-Schmiedeberg's archives of pharmacology
    68. DRINGENBERG HC; DESOUZASILVA MA; ROSSMULLER J; HUSTON JP; SCHWARTING RKW
      HISTAMINE H-1 RECEPTOR ANTAGONISTS PRODUCE INCREASES IN EXTRACELLULARACETYLCHOLINE IN RAT FRONTAL-CORTEX AND HIPPOCAMPUS

      Journal of neurochemistry
    69. MATSUNAGA K; SATO T; SHUTO H; TSURUTA Y; SUEMARU K; GOMITA Y; OISHI R
      INHIBITION OF NEURONAL DOPAMINE UPTAKE BY SOME ANTIALLERGIC DRUGS

      European journal of pharmacology
    70. PICHAT P; ANGEL I; ARBILLA S
      ANTIINFLAMMATORY PROPERTIES OF MIZOLASTINE AFTER ORAL-ADMINISTRATION ON ARACHIDONIC ACID-INDUCED CUTANEOUS REACTION IN THE RAT

      Arzneimittel-Forschung
    71. GOLDHILL J; PICHAT P; ROOME N; ANGEL I; ARBILLA S
      EFFECT OF MIZOLASTINE ON VISCERAL SENSORY AFFERENT SENSITIVITY AND INFLAMMATION DURING EXPERIMENTAL COLITIS

      Arzneimittel-Forschung
    72. PRAKASH A; LAMB HM
      MIZOLASTINE - A REVIEW OF ITS USE IN ALLERGIC RHINITIS AND CHRONIC IDIOPATHIC URTICARIA

      Biodrugs
    73. ASLANIAN R; PIWINSKI JJ
      NEW DIRECTIONS IN ANTIHISTAMINE RESEARCH

      Expert opinion on therapeutic patents
    74. BLAZSO G; GABOR M
      EVALUATION OF THE ANTI-EDEMATOUS EFFECTS OF SOME H-1-RECEPTOR ANTAGONISTS AND METHYSERGIDE IN RATS

      Pharmacological research
    75. ZHANG MQ; TIMMERMAN H
      MAST-CELL TRYPTASE AND ASTHMA

      Mediators of inflammation
    76. SUZUKI T; MORI T; TSUJI M; MISAWA M; ONODERA K
      GENERALIZATION OF D-CHLORPHENIRAMINE, L-CHLORPHENIRAMINE AND DL-CHLORPHENIRAMINE AND ZOLANTIDINE TO THE DISCRIMINATIVE STIMULUS EFFECTS OF COCAINE AND METHAMPHETAMINE

      Behavioural pharmacology
    77. DOVE S; BUSCHAUER A
      STEPWISE LEAVE-ONE-ISOMER-OUT FREE-WILSON APPROACHES AS PREPROCESSINGTOOLS IN QSAR ANALYSIS OF RACEMATES

      Quantitative structure-activity relationships
    78. WESSEL F; MARAZZI P; SOTOROMAN L; CZARLEWSKI W; DANZIG MR
      THE EFFECT OF THE NONSEDATING ANTIHISTAMINES LORATADINE AND TERFENADINE ON SEASONAL ALLERGIC RHINITIS IN PATIENTS WITH CONTROLLED BRONCHIAL-ASTHMA

      Advances in therapy
    79. DIVANOVIC A; MELAC M; HERMAN D
      CETIRIZINE (20 MG DAY) VERSUS PLACEBO IN THE PREVENTION OF REACTIONS SECONDARY TO ACCELERATED DESENSITIZATION TO HYMENOPTERA VENOMS/

      Revue francaise d'allergologie et d'immunologie clinique
    80. DUCIC I; KO CM; SHUBA Y; MORAD M
      COMPARATIVE EFFECTS OF LORATADINE AND TERFENADINE ON CARDIAC K+ CHANNELS

      Journal of cardiovascular pharmacology
    81. GENOVESE A; SPADARO G
      HIGHLIGHTS IN CARDIOVASCULAR EFFECTS OF HISTAMINE AND H-1-RECEPTOR ANTAGONISTS

      Allergy
    82. BROCKOW K; KIEHN M; RIETHMULLER C; VIELUF D; BERGER J; RING J
      EFFICACY OF ANTIHISTAMINE PRETREATMENT IN THE PREVENTION OF ADVERSE REACTIONS TO HYMENOPTERA IMMUNOTHERAPY - A PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

      Journal of allergy and clinical immunology
    83. CABALLERO R; DELPON E; VALENZUELA C; LONGOBARDO M; FRANQUEZA L; TAMARGO J
      EFFECT OF DESCARBOETHOXYLORATADINE, THE MAJOR METABOLITE OF LORATADINE, ON THE HUMAN CARDIAC POTASSIUM CHANNEL KV1.5

      British Journal of Pharmacology
    84. SUZUKI T; MORI T; TSUJI M; MISAWA M; ONODERA K
      INTERACTIONS BETWEEN H-1-ANTAGONISTS AND OPIOIDS - A DRUG DISCRIMINATION STUDY

      Psychopharmacology
    85. SUZUKI T; MORI T; TAKAMORI K; ONODERA K; MISAWA M
      EFFECTS OF H-1-ANTAGONISTS ON DISCRIMINATIVE STIMULUS EFFECTS OF COCAINE AND METHAMPHETAMINE IN RATS

      Behavioural pharmacology
    86. SU L; GUESS HA; GIRMAN CJ; JACOBSEN SJ; OESTERLING JE; PANSER LA; LIEBER MM
      ADVERSE-EFFECTS OF MEDICATIONS ON URINARY SYMPTOMS AND FLOW-RATE - A COMMUNITY-BASED STUDY

      Journal of clinical epidemiology
    87. VORPERIAN VR; ZHOU ZF; MOHAMMAD S; HOON TJ; STUDENIK C; JANUARY CT
      TORSADE-DE-POINTES WITH AN ANTIHISTAMINE METABOLITE - POTASSIUM CHANNEL BLOCKADE WITH DESMETHYLASTEMIZOLE

      Journal of the American College of Cardiology
    88. GUTIERREZ B; DORDAL A; FORT M; GALICIA J; FARRE AJ
      EFFECTS OF E-4716, A NEW ANTIHISTAMINIC WITH ANTIALLERGIC PROPERTIES,ON CHEMICAL MEDIATORS INDUCTION OF IMMUNOLOGICAL REACTIONS

      Methods and findings in experimental and clinical pharmacology
    89. DUBUSKE LM
      CLINICAL COMPARISON OF HISTAMINE H-1-RECEPTOR ANTAGONIST DRUGS

      Journal of allergy and clinical immunology
    90. BURDE R; DIPPEL E; SEIFERT R
      RECEPTOR-INDEPENDENT G-PROTEIN ACTIVATION MAY ACCOUNT FOR THE STIMULATORY EFFECTS OF FIRST-GENERATION H-1-RECEPTOR ANTAGONISTS IN HL-60 CELLS, BASOPHILS, AND MAST-CELLS

      Biochemical pharmacology
    91. HORAK F; JAGER S; TOTH J; BERGER U
      EFFICACY AND TOLERABILITY OF ASTEMIZOLE-D AND LORATADINE-D DURING PROLONGED, CONTROLLED ALLERGEN CHALLENGE IN THE VIENNA CHALLENGE CHAMBER

      Arzneimittel-Forschung
    92. WANG DY; CLEMENT P; SMITZ J
      EFFECT OF H-1 AND H-2 ANTAGONISTS ON NASAL SYMPTOMS AND MEDIATOR RELEASE IN ATOPIC PATIENTS AFTER NASAL ALLERGEN CHALLENGE DURING THE POLLEN SEASON

      Acta oto-laryngologica
    93. DUBUSKE L
      DOSE-RANGING COMPARATIVE-EVALUATION OF CETIRIZINE IN PATIENTS WITH SEASONAL ALLERGIC RHINITIS

      Annals of allergy, asthma, & immunology
    94. TERLAAK AM; TIMMERMAN H; LEURS R; NEDERKOORN PHJ; SMIT MJ; DENKELDER GMDO
      MODELING AND MUTATION STUDIES ON THE HISTAMINE H-1-RECEPTOR AGONIST BINDING-SITE REVEAL DIFFERENT BINDING MODES FOR H-1-AGONISTS - ASP(116)(TM3) HAS A CONSTITUTIVE ROLE IN RECEPTOR STIMULATION

      Journal of computer-aided molecular design
    95. HOLEN E; ELSAYED S; NYFORS A
      THE EFFECT OF H-1 RECEPTOR ANTAGONISTS ON PERIPHERAL-BLOOD MONONUCLEAR-CELLS, ADENOID CELLS AND PRIMARY-CELL LINES

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    96. MOR S; NAGLER A; BARAK V; HANDZEL ZT; GELLERBERNSTEIN C; FABIAN I
      HISTAMINE ENHANCES GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND INTERLEUKIN-6 PRODUCTION BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS

      Journal of leukocyte biology
    97. YANAI K; RYU JH; WATANABE T; IWATA R; IDO T; ASAKURA M; MATSUMURA R; ITOH M
      POSITRON EMISSION TOMOGRAPHIC STUDY OF CENTRAL HISTAMINE H-1-RECEPTOROCCUPANCY IN HUMAN-SUBJECTS TREATED WITH EPINASTINE, A 2ND-GENERATIONANTIHISTAMINE

      Methods and findings in experimental and clinical pharmacology
    98. DEPOORTERE H; DECOBERT M; GRANGER P; FRANCON D
      MIZOLASTINE, A NOVEL SELECTIVE HISTAMINE H-1 RECEPTOR ANTAGONIST - LACK OF SEDATIVE POTENTIAL ON THE EEG IN THE RODENT

      Neuropsychobiology
    99. SIMONS FER; MURRAY HE; SIMONS KJ
      QUANTITATION OF H-1-RECEPTOR ANTAGONISTS IN SKIN AND SERUM

      Journal of allergy and clinical immunology
    100. YANAI K; RYU JH; WATANABE T; IWATA R; IDO T; SAWAI Y; ITO K; ITOH M
      HISTAMINE H-1 RECEPTOR OCCUPANCY IN HUMAN BRAINS AFTER SINGLE ORAL DOSES OF HISTAMINE H-1 ANTAGONISTS MEASURED BY POSITRON EMISSION TOMOGRAPHY

      British Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/08/20 alle ore 12:51:31